Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

92
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
92
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

142
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
142
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

59
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
59
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.4K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.6K
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

93
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
93

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammation Exacerbates Congenital Zika Virus Infection and Naringenin Provides Protective Effects.

Viruses·2026
Same author

Response to Comment on 'Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure'.

International journal of epidemiology·2026
Same author

Difference in neutralizing antibodies percentages against SARS-CoV-2 in vaccinated breastfeeding women's milk and blood.

Ciencia & saude coletiva·2026
Same author

Use of high-flow nasal cannula as primary support for acute viral bronchiolitis.

Critical care science·2026
Same author

[Prevalence of burden among caregivers of children admitted to intensive care units in Rio de Janeiro, Brazil].

Ciencia & saude coletiva·2026
Same author

Hypoplastic Left Heart Syndrome: Three-Dimensional Virtual Navigation of Fetal Heart Chambers and Great Vessels.

Echocardiography (Mount Kisco, N.Y.)·2025

Related Experiment Video

Updated: Nov 11, 2025

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

188

Children's Multisystem inflammatory syndrome with myopathy.

Zina Maria Almeida de Azevedo1,2, Karla Gonçalves Camacho1, Daniella Mancino da Luz Caixeta1

  • 1Fundação Oswaldo Cruz, Instituto Nacional Fernandes Figueira, Departamento de Pediatria, Unidade de Terapia Intensiva, Rio de Janeiro, RJ, Brasil.

Revista Da Sociedade Brasileira De Medicina Tropical
|March 24, 2021
PubMed
Summary

This case report details a child with multisystem inflammatory syndrome who developed toxic shock syndrome. The condition involved coronary artery issues and neurological complications, including corpus callosum changes and muscle damage.

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.2K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.1K

Related Experiment Videos

Last Updated: Nov 11, 2025

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

188
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.2K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.1K

Area of Science:

  • Pediatric rheumatology
  • Pediatric infectious diseases
  • Pediatric neurology

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition.
  • Early recognition and management are crucial for favorable outcomes.

Observation:

  • A pediatric case of MIS-C presented with features mimicking toxic shock syndrome.
  • The patient exhibited coronary artery ectasia and neurological involvement.

Findings:

  • Magnetic resonance imaging revealed significant changes in the corpus callosum.
  • Myopathy was identified in the pelvic girdle and paravertebral muscles.

Implications:

  • This case highlights the diverse neurological and cardiovascular manifestations of MIS-C.
  • Understanding these patterns aids in early diagnosis and targeted treatment strategies.